Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.35 |
| ▸ | NR5A2 | O00482 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1010914 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL11181371 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL9122406 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL1012468 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL679390 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL1011861 | 1.00 | SCD (0.37) | SCDSPHK1NR5A2CYP1A2NR5A1 | |
| SCHEMBL797511 | 0.98 | SCD (0.34) | SCDSPHK1NR5A2MEN1KMT2A | |
| SCHEMBL239983 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL21411456 | 0.82 | — | — | |
| SCHEMBL2961195 | 0.74 | SCD (0.45) | SCDNR5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7105617-B2 | Metal 8-hydroxyquinoline-functionalized polymers and related materials and methods of making and using the same | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-09-12 | — | — | US | disclosed |
| US-20050131175-A1 | Metal 8-hydroxyquinoline-functionalized polymers and related materials and methods of making and using the same | GEORGIA TECH RESEARCH CORPORATION | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131175-A1 | Metal 8-hydroxyquinoline-functionalized polymers and related materials and methods of making and using the same | KCNQ2, KCNQ3, KCNQ1 | SCD 3393/4885SPHK1 4827/4885NR5A2 2365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.